Unlocking the Missing Puzzle Piece in Cancer Real-World Data

Carevive OPT-IN™ - Unlocking the Missing Puzzle Piece in Cancer Real-World Data

Carevive SMART Data™Carevive SMART Data

A novel, real-world dataset that presents the most comprehensive picture of the holistic experience of patients with cancer.

  • The life science industry today continues to have an unmet need for data that can inform decisions that positively impact the experience and outcomes of patients with cancer.
  • Carevive uses our digital oncology platform to collect information from patients about their experience at weekly time points during treatment.
  • These data are combined with demographic and clinical data to create Carevive SMART Data™ (Symptom Monitoring with Applied Remote Technology) consisting of longitudinal data describing:
    • symptoms,
    • quality of life,
    • physical function,
    • healthcare resource utilization.
  • The Carevive SMART dataset is available for license to life science companies who would like to analyze the unique patient-centric dataset combining longitudinal patient-reported outcomes (PRO) with EHR-derived clinical data.
  • By listening to the patient’s voice in cancer care, life science companies can address many questions regarding the patient experience in cancer which have not yet been answered by big data.

“We are excited about SMART Data and the holistic view of the patient experience that it provides. Since launching our OPT-IN registries, we are already seeing the value this longitudinal dataset creates for improving patient care and outcomes.
We invite life science companies to join the SMART Data conversation and answer pressing questions about real-world patients with cancer.”

Mordecai KramerVP, Data Generation & Outcomes, Life Sciences

Collecting Patient Experience Data

Carevive SMART Data™

Value Proposition for Life Science Companies and Novel Use Cases

Provide Commercial Insights
Inform new drug development and new indications
Support Market Access
  • How are patients doing on treatment across multiple domains of Patient Experience?
  • How is this impacted by demographics? Social determinants of health?
  • How do clinicians use and respond to longitudinal PRO data?
  • How does the Patient Experience change over time and with disease progression?
  • How is work productivity impacted by the disease and treatment?
  • How bothersome is treatment and what symptoms are most bothersome to the patient?

Carevive OPT-IN® - Logo

Building the Largest Real-World Cancer Patient Experience Database

Carevive OPT-IN® – The Oncology Pragmatic Trial Investigator Network

Funded by a growing list of life science companies, Carevive OPT-IN® is a novel and unique real-world patient experience dataset consisting of EHR-derived clinical data and longitudinal patient-reported outcomes (PRO). Together, this combination presents the most comprehensive picture of real-world symptoms of disease and treatment in cancer.

Life science companies can license these data to:

  • Support drug development, commercial, and market access efforts with novel evidence and insights including how and when therapies are being used in the real-world setting, differences between trial results and real-world data and longitudinal patient experience
  • Conduct bespoke research in collaboration with Carevive OPT-IN® sites and their patients
  • Become Carevive design-partners in other cancer types

Tumor registries to be initiated in 2020-2022

Myeloma

LIVE

Chronic Lymphocytic Leukemia
Renal Cell Carcinoma
Breast Cancer

LIVE

DLBCL
Follicular Lymphoma
Urothelial
Lung Cancer

LIVE

Ovarian Cancer

LIVE

Hepatocellular Carcinoma
Prostate Cancer
AML

LIVE

Stomach Cancer
Colorectal Carcinoma
Pancreatic Cancer
Head and Neck
0
Average datapoints per patient
0
Average symptoms per patient
0
%
Adherence: Weekly PROs

OPT-imizing Patient Experience Data

REQUEST A MEETING TO LEARN MORE
Carevive OPT-IN™ - Cancer Real-World Data